The Use of Clinical Holds Following Clinical Investigator Misconduct: Guidance for Industry and Clinical Investigators
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 2, 2004
May 6, 2020
8baa9e6b-d386-4460-927e-2aa353d1ce2b
Related Documents
Independent Consultants for Biotechnology Clinical Trial Protocols: Guidance for Industry
Guidance DocumentAugust 19, 2004Office of the Commissioner
Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees: Guidance for Industry
Guidance DocumentJanuary 3, 2005Center for Drug Evaluation and Research
E9 Statistical Principles for Clinical Trials
Guidance DocumentSeptember 16, 1998Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox